Search

Displaying results 6731 - 6740 of 8575 in total
  1. Drug

    PF-03882845

    go.drugbank.com/drugs/DB11814
    Investigational

    PF-03882845 has been used in trials studying the basic science of Diabetes Mellitus, Type 2 and Type 2 Diabetic Nephropathy.

  2. Drug

    Seribantumab

    go.drugbank.com/drugs/DB11857
    Investigational

    Seribantumab has been used in trials studying the treatment of NSCLC, Heregulin, Adenocarcinoma, Colorectal Cancer, and Solid Tumor Cancers, among others.

  3. Drug

    MPT0B640

    go.drugbank.com/drugs/DB16512
    Investigational

    MPT0B640 was under investigation in clinical trials NCT04526717 for COVID-19 infection and NCT04294875 for locally advanced or metastatic solid malignancies.

  4. Drug

    OPB-111077

    go.drugbank.com/drugs/DB16630
    Investigational

    It has demonstrated promising anticancer activity in preclinical models.

  5. Drug

    KAHR-102

    go.drugbank.com/drugs/DB17427
    Investigational

    KAHR-102 is a dual signaling protein fusing cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) to the Fas-ligand (FasL).

  6. Drug

    Emprumapimod

    go.drugbank.com/drugs/DB17603
    Investigational

    It was investigated for dilated cardiomyopathy.

  7. Drug

    AZD-8055

    go.drugbank.com/drugs/DB12774
    Investigational

    AZD8055 has been used in trials studying the treatment of Cancer, Lymphomas, Solid Tumors, MALIGNANT GLIOMA, and brainstem glioma, among others.

  8. Drug

    Trofosfamide

    go.drugbank.com/drugs/DB12902
    Investigational

    Trofosfamide has been used in trials studying the treatment of Ependymomas, Medulloblastomas, Sarcoma, Soft Tissue, Supratentorial PNETs, and Recurrent Brain Tumors.

  9. Drug

    Camsirubicin

    go.drugbank.com/drugs/DB13103
    Investigational

    GPX-150 has been used in trials studying the treatment of Soft Tissue Sarcoma and Advanced Solid Tumors - Phase 1 Population.

  10. Drug

    Timapiprant

    go.drugbank.com/drugs/DB11900
    Investigational

    OC000459 has been investigated for the treatment of Bronchial Asthma.